0001786499-19-000002.txt : 20191113 0001786499-19-000002.hdr.sgml : 20191113 20191113124524 ACCESSION NUMBER: 0001786499-19-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20191113 DATE AS OF CHANGE: 20191113 EFFECTIVENESS DATE: 20191113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bioverge Funds, EnClear Therapies II, a series of Bioverge Funds II, LLC CENTRAL INDEX KEY: 0001786499 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-353256 FILM NUMBER: 191212797 BUSINESS ADDRESS: STREET 1: PO BOX 171305 CITY: SALT LAKE CITY STATE: UT ZIP: 84117 BUSINESS PHONE: 8014190677 MAIL ADDRESS: STREET 1: PO BOX 171305 CITY: SALT LAKE CITY STATE: UT ZIP: 84117 FORMER COMPANY: FORMER CONFORMED NAME: Bioverge Funds, EnClear II, a Series of Bioverge Funds II, LLC DATE OF NAME CHANGE: 20190826 D 1 primary_doc.xml X0708 D LIVE 0001786499 Bioverge Funds, EnClear Therapies II, a series of Bioverge Funds II, LLC 6510 S Millrock Drive Suite 400 Salt Lake City UT UTAH 84121 (801) 419-0677 DELAWARE None Bioverge Funds, EnClear II, a Series of Bioverge Funds II, LLC Limited Liability Company true 2019 LLC Assure Fund Management II PO Box 171305 Salt Lake City UT UTAH 84117 Director Issuer's Manager Richard Thoms PO Box 171305 Salt Lake City UT UTAH 84117 Executive Officer Officer of the Issuer's Manager Jeremy Neilson PO Box 171305 Salt Lake City UT UTAH 84117 Executive Officer Managing Director of the Issuer's Manager Pooled Investment Fund Other Investment Fund false Decline to Disclose 06b 3C.1 false 2019-11-12 false true false 5000 153980 153980 0 false 24 0 0 8000 This amount represents a one-time cost to cover fund organizational and operating expenses. Bioverge Funds, EnClear Therapies II, a series of Bioverge Funds II, LLC Richard Thoms Richard Thoms Officer of the Issuer's Manager 2019-11-12